Clinical manifestations of immediate hypersensitivity (allergic) diseases are caused by the release of proinflammatory mediators (histamine, leukotrienes, and prostaglandins) from immunoglobulin E (IgE)-sensitized effector cells (mast cells and basophils) when cell-bound IgE antibodies interact with allergen. The allergens chosen for testing often depend upon the age of the patient, history of allergen exposure, season of the year, and clinical manifestations. In individuals predisposed to develop allergic disease, the sequence of sensitization and clinical manifestations proceed as follows: eczema and respiratory disease (rhinitis and bronchospasm) in infants and children less than 5 years due to food sensitivity (milk, egg, soy, and wheat proteins) followed by respiratory disease (rhinitis and asthma) in older children and adults due to sensitivity to inhalant allergens (dust mite, mold, and pollen inhalants). Blomia tropicalis, a storage mite found predominantly in agricultural environments, is an important contributor to the allergen content in house dust in tropical and subtropical regions. Allergens produced by blomia tropicalis are an important cause of IgE-mediated sensitization among patients with asthma. The presence of allergen specific IgE antibodies in serum of a patient is highly predictive of the likelihood that the individual will exhibit immediate hypersensitivity upon exposure to the allergen.
No special preparation is needed for Allergen Blomia Tropicalis Immunocap Blood Serum. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing Allergen Blomia Tropicalis Immunocap Blood Serum. Your doctor depending on your condition will give specific instructions.
|UNISEX||All age groups||<0.35 Negative|